Accord Healthcare is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 85 markets around the world.
Accord Healthcare is the international arm of Intas Pharmaceuticals Ltd., with commercial operations in more than 85 countries globally. The first Accord commercial operations in Europe were recorded in 2008 in the United Kingdom and now extends to 11 countries in Asia Pacific with a portfolio comprising 310 registered molecules in Asia Pacific.
A COMPLETE APPROACH
Accord’s vision is to be involved in all aspects of bringing pharmaceuticals to patients. Our activities today encompass the entire pharmaceutical value chain and so create a truly integrated offering.
GROWTH’S IN OUR NATURE
With an extensive presence in all regions of the world, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies.
Our robust product portfolio in growth-oriented therapies allows us to compete with some of the biggest portfolios in the industry, as well as helping to extend our presence into new markets.
Accord’s operations began with a strategic vision to create a global brand, supported by a commercial infrastructure that enables us to bring our high quality yet affordable products to patients around the world. We commit ourselves to challenging the unmet medical, societal and patient needs of the day.